Tencent generates tens of billions in annual free cash flow and operates an internal investment arm (a 'sequoia fund on steroids') that deploys this capital into private deals at companies that have achieved certain milestones, avoiding large stakes to preserve optionality, with a track record of investing in 15-20+ unicorns and matching or exceeding the returns of top-tier venture capitalists.